Literature DB >> 11179450

Short- and long-term functional alterations of the skeletal muscle calcium release channel (Ryanodine receptor) by Suramin: apparent dissociation of single channel current recording and [3H]ryanodine binding.

J Suko1, G Hellmann, H Drobny.   

Abstract

The present study demonstrates the following characteristic suramin actions on the purified skeletal muscle calcium release channel in single-channel current recordings and [(3)H]ryanodine binding to HSR: 1) Suramin (0.3-0.9 mM) induced a concentration-dependent increase in the open probability (P(o) congruent with 0.9) at 20 to 100 microM Ca(2+) and an almost fully open channel at 1 mM Ca(2+) (P(o) = 0.95) with a marked shift to longer open states (tau(o)3/tau(o)4). Suramin increased the apparent calcium affinity to the activating high-affinity calcium binding sites and reduced the apparent magnesium affinity to the inhibitory low affinity Ca(2+)/Mg(2+) binding sites. 2) Channel activation by suramin and sulfhydryl oxidation was additive. 3) Suramin (0.9 mM) reversed the Ca-calmodulin-induced channel inhibition at 0.1 or 1 to 5 microM Ca-calmodulin. 4) The open probability of the suramin activated channel was almost completely inhibited by 10 mM Mg(2+) or Ca(2+) on short suramin exposure. Prolonged suramin exposure (30-60 min) resulted in a time-dependent, slow increase in P(o), with long open states of low frequency in the presence of 10 to 20 mM Mg(2+) or Ca(2+). 5) Magnesium induced inhibition of P(o) (IC(50) = 0.38 mM) and equilibrium [(3)H]ryanodine binding (IC(50) = 0.30 mM) agreed well in control channels, but were dissociated in the presence of 0.9 to 1.0 mM suramin (IC(50) = 0.82 mM versus 83 mM). [(3)H]ryanodine binding seemed to monitor predominantly the long-term alteration in channel function. 6) The multiple effects of suramin on channel function suggest an allosteric mechanism and no direct effects on binding of endogenous ligands involved in channel gating.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11179450     DOI: 10.1124/mol.59.3.543

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  4 in total

1.  Use-dependent inhibition of the skeletal muscle ryanodine receptor by the suramin analogue NF676.

Authors:  Ilse Wolner; Matthias U Kassack; Heiko Ullmann; Anton Karel; Martin Hohenegger
Journal:  Br J Pharmacol       Date:  2005-10       Impact factor: 8.739

2.  Regulation of the calcium release channel from skeletal muscle by suramin and the disulfonated stilbene derivatives DIDS, DBDS, and DNDS.

Authors:  Erin R O'Neill; Magdalena M Sakowska; Derek R Laver
Journal:  Biophys J       Date:  2003-03       Impact factor: 4.033

3.  Nicotinic acid-adenine dinucleotide phosphate activates the skeletal muscle ryanodine receptor.

Authors:  Martin Hohenegger; Josef Suko; Regina Gscheidlinger; Helmut Drobny; Andreas Zidar
Journal:  Biochem J       Date:  2002-10-15       Impact factor: 3.857

Review 4.  Insect ryanodine receptors: molecular targets for novel pest control chemicals.

Authors:  David B Sattelle; Daniel Cordova; Timothy R Cheek
Journal:  Invert Neurosci       Date:  2008-08-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.